Person · CIK 1264519

Paul J Sekhri

Director at Veeva Systems, Apnimed and Longboard Pharmaceuticals; Pres at vTv Therapeutics

Earlier: Axcella Health, BiomX, Alpine Immune Sciences, Enumeral Biomedical Holdings, ARYx Therapeutics, Biodel and Ariad Pharmaceuticals

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$8.4M

Noticed on Form 144$562K

Bought on Form 4$334K

Companies11

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

Company	Security	Held	Shares or units	As of
Veeva Systems VEEV	Class A Common Stock	Directly	15,651	Sep 1, 2026 · Filing · EDGAR
Veeva Systems VEEV	Restricted Stock Units into Class A Common Stock	Directly	1,381	Sep 1, 2026 · Filing · EDGAR
Apnimed APMD	Common Stock	Directly	12,500	Aug 3, 2026 · Filing · EDGAR
Apnimed APMD	Stock Option (Right to Buy) exercise $8.15, expires May 28, 2036, into Common Stock	Directly	169,468	Aug 3, 2026 · Filing · EDGAR
Apnimed APMD	Stock Option (Right to Buy) exercise $16.00, expires Jul 29, 2036, into Common Stock	Directly	155,558	Aug 3, 2026 · Filing · EDGAR
Apnimed APMD	Stock Option (Right to Buy) exercise $16.00, expires Jul 29, 2036, into Common Stock	Directly	22,238	Aug 3, 2026 · Filing · EDGAR
vTv Therapeutics VTVT	Class A Common Stock	Directly	5,000	Nov 18, 2024 · Filing · EDGAR
vTv Therapeutics VTVT	Class A Common Stock exercise $36.92, expires Feb 17, 2036, into Class A Common Stock ("Common Stock")	Directly	392,212	Feb 17, 2026 · Filing · EDGAR
Axcella Health	Stock Option (Right to Buy) exercise $1.70, expires May 18, 2032, into Common Stock	Directly	40,000	May 19, 2022 · Filing · EDGAR
BiomX	Common Stock	Directly	12,500	Jul 28, 2021 · Filing · EDGAR
BiomX	Common Stock Warrant exercise $5.00, expires Jan 28, 2027, into Common Stock	Directly	9,375	Jul 28, 2021 · Filing · EDGAR
Alpine Immune Sciences	Stock Option (Right to buy) exercise $3.62, expires Jan 1, 2030, into Common Stock	Directly	7,650	Jan 2, 2020 · Filing · EDGAR
Enumeral Biomedical Holdings	Common Stock	Directly	175,000	Dec 9, 2016 · Filing · EDGAR

Sold and noticed by quarter

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table

Quarter	Sold (Form 4)	Noticed (Form 144)	Bought (Form 4)
Q3 2026	—	—	$200K
Q4 2024	—	—	$84K
Q3 2023	$562K	$562K	—
Q1 2023	$484K	Not machine-readable	—
Q1 2022	$2.4M	Not machine-readable	—
Q3 2021	—	—	$50K
Q2 2021	$553K	Not machine-readable	—
Q1 2020	$270K	Not machine-readable	—
Q4 2019	$769K	Not machine-readable	—
Q2 2019	$102K	Not machine-readable	—
Q1 2019	$77K	Not machine-readable	—
Q4 2018	$1.4M	Not machine-readable	—
Q3 2018	$62K	Not machine-readable	—
Q2 2018	$92K	Not machine-readable	—
Q1 2018	$384K	Not machine-readable	—
Q4 2017	$591K	Not machine-readable	—
Q4 2016	$664K	Not machine-readable	—

Form 144 notices went onto EDGAR as structured data on April 13, 2023. Earlier notices were filed on paper and cannot be read here, so those quarters show no noticed amount.

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice date	Noticed	Planned sale	Outcome	Links
Veeva Systems VEEV · UBS Financial Services · 10b5-1 plan adopted Dec 20, 2022 · 1 notice
Sep 11, 2023	2,500 · ~$562K	Sep 11, 2023	Sold as noticed Sold 2,500 at $224.85 on Sep 11 · $562K Form 4	Filing · EDGAR
Sales without a matching Form 144 · 21 sales No matching Form 144 found. Not every sale needs one: small sales and sales by people who are not affiliates are exempt.
—	—	—	Notice not machine-readable Veeva Systems (VEEV): Sold 118 at $183.51 on Mar 3, 2023 · $22K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Veeva Systems (VEEV): Sold 2,540 at $181.85 on Mar 3, 2023 · $462K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Veeva Systems (VEEV): Sold 11,000 at $214.02 on Mar 31, 2022 · $2.4M	Filing · EDGAR
—	—	—	Notice not machine-readable Veeva Systems (VEEV): Sold 1,839 at $300.61 on Jun 17, 2021 · $553K	Filing · EDGAR
—	—	—	Notice not machine-readable Veeva Systems (VEEV): Sold 1,854 at $145.50 on Mar 27, 2020 · $270K	Filing · EDGAR
—	—	—	Notice not machine-readable Veeva Systems (VEEV): Sold 4,615 at $146.11 on Dec 6, 2019 · $674K	Filing · EDGAR
—	—	—	Notice not machine-readable Veeva Systems (VEEV): Sold 628 at $151.00 on Oct 4, 2019 · $95K	Filing · EDGAR
—	—	—	Notice not machine-readable Veeva Systems (VEEV): Sold 601 at $169.38 on Jun 24, 2019 · $102K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Veeva Systems (VEEV): Sold 600 at $127.53 on Mar 22, 2019 · $77K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Veeva Systems (VEEV): Sold 601 at $85.00 on Dec 26, 2018 · $51K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Veeva Systems (VEEV): Sold 1,225 at $87.44 on Dec 18, 2018 · $107K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Veeva Systems (VEEV): Sold 7,804 at $86.57 on Dec 18, 2018 · $676K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Veeva Systems (VEEV): Sold 1,300 at $99.09 on Dec 3, 2018 · $129K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Veeva Systems (VEEV): Sold 3,206 at $98.17 on Dec 3, 2018 · $315K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Veeva Systems (VEEV): Sold 1,510 at $97.09 on Dec 3, 2018 · $147K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Veeva Systems (VEEV): Sold 601 at $103.67 on Sep 24, 2018 · $62K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Veeva Systems (VEEV): Sold 1,107 at $82.80 on Jun 25, 2018 · $92K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Veeva Systems (VEEV): Sold 1,108 at $75.46 on Mar 23, 2018 · $84K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Veeva Systems (VEEV): Sold 4,622 at $65.00 on Feb 28, 2018 · $300K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Veeva Systems (VEEV): Sold 10,971 at $53.83 on Dec 7, 2017 · $591K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Veeva Systems (VEEV): Sold 17,593 at $37.73 on Oct 11, 2016 · $664K (10b5-1 plan)	Filing · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Veeva Systems VEEV Director · filings 2014 to 2026 · sold $8.4M · $562K noticed on Form 144

Date	Transaction	Shares	Price	Value	Held after	Source
Sep 1, 2026	Option or RSU exercised or converted	+460			15,651 direct	Filing · EDGAR
Sep 1, 2026	Option or RSU exercised or converted Restricted Stock Units	−460			1,381 direct	Filing · EDGAR
Jun 17, 2026	Grant or award from the company Restricted Stock Units	+1,841			1,841 direct	Filing · EDGAR
Jun 1, 2026	Option or RSU exercised or converted	+253			15,191 direct	Filing · EDGAR
Jun 1, 2026	Option or RSU exercised or converted Restricted Stock Units	−253			0 direct	Filing · EDGAR
Mar 1, 2026	Option or RSU exercised or converted	+253			14,938 direct	Filing · EDGAR
Mar 1, 2026	Option or RSU exercised or converted Restricted Stock Units	−253			253 direct	Filing · EDGAR
Dec 2, 2025	Gift	−2,491			14,685 direct	Filing · EDGAR
Dec 1, 2025	Option or RSU exercised or converted	+254			17,176 direct	Filing · EDGAR
Dec 1, 2025	Option or RSU exercised or converted Restricted Stock Units	−254			506 direct	Filing · EDGAR
Sep 1, 2025	Option or RSU exercised or converted	+253			16,922 direct	Filing · EDGAR
Sep 1, 2025	Option or RSU exercised or converted Restricted Stock Units	−253			760 direct	Filing · EDGAR
Jun 18, 2025	Grant or award from the company Restricted Stock Units	+1,013			1,013 direct	Filing · EDGAR
Jun 1, 2025	Option or RSU exercised or converted	+329			16,669 direct	Filing · EDGAR
Jun 1, 2025	Option or RSU exercised or converted Restricted Stock Units	−329			0 direct	Filing · EDGAR
Mar 1, 2025	Option or RSU exercised or converted	+328			16,340 direct	Filing · EDGAR
Mar 1, 2025	Option or RSU exercised or converted Restricted Stock Units	−328			329 direct	Filing · EDGAR
Dec 1, 2024	Option or RSU exercised or converted	+329			16,012 direct	Filing · EDGAR
Dec 1, 2024	Option or RSU exercised or converted Restricted Stock Units	−329			657 direct	Filing · EDGAR
Sep 1, 2024	Option or RSU exercised or converted	+329			15,683 direct	Filing · EDGAR
Sep 1, 2024	Option or RSU exercised or converted Restricted Stock Units	−329			986 direct	Filing · EDGAR
Jun 19, 2024	Grant or award from the company Restricted Stock Units	+1,315			1,315 direct	Filing · EDGAR
Jun 1, 2024	Option or RSU exercised or converted	+290			15,354 direct	Filing · EDGAR
Jun 1, 2024	Option or RSU exercised or converted Restricted Stock Units	−290			0 direct	Filing · EDGAR
Mar 1, 2024	Option or RSU exercised or converted	+290			15,064 direct	Filing · EDGAR
Mar 1, 2024	Option or RSU exercised or converted Restricted Stock Units	−290			290 direct	Filing · EDGAR
Dec 1, 2023	Option or RSU exercised or converted	+290			14,774 direct	Filing · EDGAR
Dec 1, 2023	Option or RSU exercised or converted Restricted Stock Units	−290			580 direct	Filing · EDGAR
Sep 11, 2023	Sale under a 10b5-1 plan	−2,500	$224.85	$562K	14,484 direct	Filing · EDGAR
Sep 1, 2023	Option or RSU exercised or converted	+290			16,984 direct	Filing · EDGAR
Sep 1, 2023	Option or RSU exercised or converted Restricted Stock Units	−290			870 direct	Filing · EDGAR
Jun 21, 2023	Grant or award from the company Restricted Stock Units	+1,160			1,160 direct	Filing · EDGAR
Jun 1, 2023	Option or RSU exercised or converted	+313			16,694 direct	Filing · EDGAR
Jun 1, 2023	Option or RSU exercised or converted Restricted Stock Units	−313			0 direct	Filing · EDGAR
Mar 3, 2023	Sale under a 10b5-1 plan	−2,540	$181.85	$462K	16,499 direct	Filing · EDGAR
Mar 3, 2023	Sale under a 10b5-1 plan	−118	$183.51	$22K	16,381 direct	Filing · EDGAR
Mar 1, 2023	Option or RSU exercised or converted	+313			19,039 direct	Filing · EDGAR
Mar 1, 2023	Option or RSU exercised or converted Restricted Stock Units	−313			313 direct	Filing · EDGAR
Dec 16, 2022	Gift	−702			18,726 direct	Filing · EDGAR
Dec 1, 2022	Option or RSU exercised or converted	+313			19,428 direct	Filing · EDGAR
Dec 1, 2022	Option or RSU exercised or converted Restricted Stock Units	−313			626 direct	Filing · EDGAR
Sep 1, 2022	Option or RSU exercised or converted	+313			19,115 direct	Filing · EDGAR
Sep 1, 2022	Option or RSU exercised or converted Restricted Stock Units	−313			939 direct	Filing · EDGAR
Jun 9, 2022	Grant or award from the company Restricted Stock Units	+1,252			1,252 direct	Filing · EDGAR
Jun 1, 2022	Option or RSU exercised or converted	+189			18,802 direct	Filing · EDGAR
Jun 1, 2022	Option or RSU exercised or converted Restricted Stock Units	−189			0 direct	Filing · EDGAR
Mar 31, 2022	Open-market or private sale	−11,000	$214.02	$2.4M	18,613 direct	Filing · EDGAR
Mar 1, 2022	Option or RSU exercised or converted	+189			29,613 direct	Filing · EDGAR
Mar 1, 2022	Option or RSU exercised or converted Restricted Stock Units	−189			189 direct	Filing · EDGAR
Dec 1, 2021	Option or RSU exercised or converted	+189			29,424 direct	Filing · EDGAR
Dec 1, 2021	Option or RSU exercised or converted Restricted Stock Units	−189			378 direct	Filing · EDGAR
Sep 1, 2021	Option or RSU exercised or converted	+189			29,235 direct	Filing · EDGAR
Sep 1, 2021	Option or RSU exercised or converted Restricted Stock Units	−189			567 direct	Filing · EDGAR
Jun 25, 2021	Option or RSU exercised or converted	+216			29,046 direct	Filing · EDGAR
Jun 25, 2021	Option or RSU exercised or converted Restricted Stock Units	−216			0 direct	Filing · EDGAR
Jun 23, 2021	Grant or award from the company Restricted Stock Units	+756			756 direct	Filing · EDGAR
Jun 17, 2021	Option or RSU exercised or converted	+20,000	$27.14	$543K	30,669 direct	Filing · EDGAR
Jun 17, 2021	Open-market or private sale	−1,839	$300.61	$553K	28,830 direct	Filing · EDGAR
Jun 17, 2021	Option or RSU exercised or converted Stock Option (right to buy)	−20,000			0 direct	Filing · EDGAR
Mar 25, 2021	Option or RSU exercised or converted	+217			10,669 direct	Filing · EDGAR

69 earlier transactions are in the filing list below.

Apnimed APMD Director · filings 2026 to 2026 · bought $200K

Date	Transaction	Shares	Price	Value	Held after	Source
Aug 3, 2026	Open-market or private purchase	+12,500	$16.00	$200K	12,500 direct	Filing · EDGAR
Aug 3, 2026	Returned to the company Stock Option (Right to Buy)	−169,468			0 direct	Filing · EDGAR
Aug 3, 2026	Grant or award from the company Stock Option (Right to Buy)	+169,468			169,468 direct	Filing · EDGAR
Aug 3, 2026	Returned to the company Stock Option (Right to Buy)	+155,558			0 direct	Filing · EDGAR
Aug 3, 2026	Grant or award from the company Stock Option (Right to Buy)	+155,558			155,558 direct	Filing · EDGAR
Aug 3, 2026	Returned to the company Stock Option (Right to Buy)	−22,238			0 direct	Filing · EDGAR
Aug 3, 2026	Grant or award from the company Stock Option (Right to Buy)	+22,238			22,238 direct	Filing · EDGAR
Jul 30, 2026	Grant or award from the company Stock Option (Right to Buy)	+155,558			155,558 direct	Filing · EDGAR
Jul 30, 2026	Grant or award from the company Stock Option (Right to Buy)	+22,238			22,238 direct	Filing · EDGAR

vTv Therapeutics VTVT Pres, CEO and Exec Chairperson · filings 2022 to 2026 · bought $84K

Date	Transaction	Shares	Price	Value	Held after	Source
Feb 17, 2026	Grant or award from the company Class A Common Stock	+140,000	$36.92	$5.2M	392,212 direct	Filing · EDGAR
Mar 1, 2025	Grant or award from the company Employee stock option (right to buy)	+108,000	$19.66	$2.1M	252,212 direct	Filing · EDGAR
Nov 18, 2024	Open-market or private purchase	+1,844	$16.96	$31K	5,000 direct	Filing · EDGAR
Nov 15, 2024	Open-market or private purchase	+1,378	$16.35	$23K	1,378 direct	Filing · EDGAR
Nov 15, 2024	Open-market or private purchase	+1,778	$16.88	$30K	3,156 direct	Filing · EDGAR
Feb 27, 2024	Grant or award from the company Employee stock option (right to buy)	+89,212	$11.81	$1.1M	144,212 direct	Filing · EDGAR

Longboard Pharmaceuticals LBPH Director · filings 2021 to 2024

Date	Transaction	Shares	Held after	Source
Dec 2, 2024	Returned to the company Employee Stock Option (right to buy)	−25,461	0 direct	Filing · EDGAR
Dec 2, 2024	Returned to the company Employee Stock Option (right to buy)	−12,367	0 direct	Filing · EDGAR
Dec 2, 2024	Returned to the company Employee Stock Option (right to buy)	−12,500	0 direct	Filing · EDGAR
Dec 2, 2024	Returned to the company Employee Stock Option (right to buy)	−22,500	0 direct	Filing · EDGAR
May 23, 2024	Grant or award from the company Stock Option (Right to Buy)	+22,500	22,500 direct	Filing · EDGAR
May 25, 2023	Grant or award from the company Stock Option (Right to Buy)	+12,500	12,500 direct	Filing · EDGAR
May 24, 2022	Grant or award from the company Stock Option (Right to Buy)	+12,367	12,367 direct	Filing · EDGAR

Axcella Health Director · filings 2022 to 2022

Date	Transaction	Shares	Price	Value	Held after	Source
May 19, 2022	Grant or award from the company Stock Option (Right to Buy)	+40,000			40,000 direct	Filing · EDGAR

BiomX Director · filings 2020 to 2021 · bought $50K

Date	Transaction	Shares	Price	Value	Held after	Source
Jul 28, 2021	Open-market or private purchase	+12,500	$4.00	$50K	12,500 direct	Filing · EDGAR
Jul 28, 2021	Open-market or private purchase Common Stock Warrant	+9,375			9,375 direct	Filing · EDGAR
Mar 30, 2021	Grant or award from the company Common Stock Options - Right to Buy	+15,200			15,200 direct	Filing · EDGAR
Oct 2, 2020	Grant or award from the company Common Stock Options - Right to Buy	+16,000			16,000 direct	Filing · EDGAR

Alpine Immune Sciences Director · filings 2016 to 2020

Date	Transaction	Shares	Held after	Source
Jan 2, 2020	Grant or award from the company Stock Option (Right to buy)	+7,650	7,650 direct	Filing · EDGAR
Jan 2, 2019	Grant or award from the company Stock Option (Right to buy)	+7,650	7,650 direct	Filing · EDGAR
Jan 2, 2018	Grant or award from the company Stock Option (Right to buy)	+7,650	7,650 direct	Filing · EDGAR
Sep 12, 2016	Grant or award from the company Stock Option (Right to Buy)	+12,300	12,300 direct	Filing · EDGAR

Enumeral Biomedical Holdings Director · filings 2015 to 2016

Date	Transaction	Shares	Price	Value	Held after	Source
Dec 9, 2016	Option or RSU exercised or converted	+175,000	$0.13	$22K	175,000 direct	Filing · EDGAR
Dec 9, 2016	Open-market or private purchase Common Stock Purchase Warrant	+43,750	$0.08	$4K	43,750 direct	Filing · EDGAR
Dec 9, 2016	Other acquisition or disposition (see the filing) Common Stock Purchase Warrant	+175,000	$0.13	$22K	175,000 direct	Filing · EDGAR
Dec 9, 2016	Option or RSU exercised or converted Common Stock Purchase Warrant	−175,000	$0.13	$22K	0 direct	Filing · EDGAR
Sep 22, 2015	Grant or award from the company Common Stock Option (Right to Buy)	+76,000			76,000 direct	Filing · EDGAR

ARYx Therapeutics Director · filings 2007 to 2010

Date	Transaction	Shares	Held after	Source
Apr 30, 2010	Grant or award from the company Stock Option (Right to Buy)	+6,666	6,666 direct	Filing · EDGAR
Apr 30, 2009	Grant or award from the company Stock Option (Right to Buy)	+6,666	6,666 direct	Filing · EDGAR
Nov 7, 2007	Grant or award from the company Stock Option (Right to Buy)	+16,666	16,666 direct	Filing · EDGAR

Biodel Director · filings 2007 to 2007

No transactions in the filings read; Form 144 notices are listed above.

Ariad Pharmaceuticals Pres./Chief Business Officer · filings 2003 to 2004

Date	Transaction	Shares	Price	Value	Held after	Source
Sep 9, 2004	Grant or award from the company Employee Stock option (right to buy)	+45,000			45,000 direct	Filing · EDGAR
Oct 1, 2003	Grant or award from the company Stock Option (Right to Buy)	+135,000			135,000 direct	Filing · EDGAR

All 108 Forms 3, 4, 5 and 144

Filed	Form	Company	Links
Sep 3, 2026	Form 4	Veeva Systems VEEV	Filing · EDGAR
Aug 3, 2026	Form 4	Apnimed APMD	Filing · EDGAR
Jul 30, 2026	Form 3	Apnimed APMD	Filing · EDGAR
Jun 22, 2026	Form 4	Veeva Systems VEEV	Filing · EDGAR
Jun 3, 2026	Form 4	Veeva Systems VEEV	Filing · EDGAR
Mar 3, 2026	Form 4	Veeva Systems VEEV	Filing · EDGAR
Feb 18, 2026	Form 4	vTv Therapeutics VTVT	Filing · EDGAR
Dec 3, 2025	Form 4	Veeva Systems VEEV	Filing · EDGAR
Sep 3, 2025	Form 4	Veeva Systems VEEV	Filing · EDGAR
Jun 20, 2025	Form 4	Veeva Systems VEEV	Filing · EDGAR
Jun 2, 2025	Form 4	Veeva Systems VEEV	Filing · EDGAR
Mar 7, 2025	Form 4	vTv Therapeutics VTVT	Filing · EDGAR
Mar 3, 2025	Form 4	Veeva Systems VEEV	Filing · EDGAR
Dec 2, 2024	Form 4	Veeva Systems VEEV	Filing · EDGAR
Dec 2, 2024	Form 4	Longboard Pharmaceuticals LBPH	Filing · EDGAR
Nov 19, 2024	Form 4	vTv Therapeutics VTVT	Filing · EDGAR
Sep 3, 2024	Form 4	Veeva Systems VEEV	Filing · EDGAR
Jun 20, 2024	Form 4	Veeva Systems VEEV	Filing · EDGAR
Jun 13, 2024	Form 4	vTv Therapeutics VTVT	Filing · EDGAR
Jun 3, 2024	Form 4	Veeva Systems VEEV	Filing · EDGAR
May 24, 2024	Form 4	Longboard Pharmaceuticals LBPH	Filing · EDGAR
Mar 5, 2024	Form 4	Veeva Systems VEEV	Filing · EDGAR
Dec 1, 2023	Form 4	Veeva Systems VEEV	Filing · EDGAR
Sep 12, 2023	Form 4	Veeva Systems VEEV	Filing · EDGAR
Sep 11, 2023	Form 144	Veeva Systems VEEV	Filing · EDGAR
Sep 5, 2023	Form 4	Veeva Systems VEEV	Filing · EDGAR
Jun 23, 2023	Form 4	Veeva Systems VEEV	Filing · EDGAR
Jun 5, 2023	Form 4	Veeva Systems VEEV	Filing · EDGAR
May 26, 2023	Form 4	Longboard Pharmaceuticals LBPH	Filing · EDGAR
Mar 6, 2023	Form 4	Veeva Systems VEEV	Filing · EDGAR
Mar 3, 2023	Form 4	Veeva Systems VEEV	Filing · EDGAR
Dec 20, 2022	Form 4	Veeva Systems VEEV	Filing · EDGAR
Dec 5, 2022	Form 4	Veeva Systems VEEV	Filing · EDGAR
Sep 6, 2022	Form 4	Veeva Systems VEEV	Filing · EDGAR
Aug 8, 2022	Form 3	vTv Therapeutics VTVT	Filing · EDGAR
Jun 13, 2022	Form 4	Veeva Systems VEEV	Filing · EDGAR
Jun 2, 2022	Form 4	Veeva Systems VEEV	Filing · EDGAR
May 31, 2022	Form 4	Longboard Pharmaceuticals LBPH	Filing · EDGAR
May 25, 2022	Form 4	Axcella Health	Filing · EDGAR
May 25, 2022	Form 3	Axcella Health	Filing · EDGAR
Apr 1, 2022	Form 4	Veeva Systems VEEV	Filing · EDGAR
Mar 3, 2022	Form 4	Veeva Systems VEEV	Filing · EDGAR
Dec 3, 2021	Form 4	Veeva Systems VEEV	Filing · EDGAR
Sep 3, 2021	Form 4	Veeva Systems VEEV	Filing · EDGAR
Jul 30, 2021	Form 4	BiomX	Filing · EDGAR
Jun 25, 2021	Form 4	Veeva Systems VEEV	Filing · EDGAR
Jun 24, 2021	Form 4	Veeva Systems VEEV	Filing · EDGAR
Jun 21, 2021	Form 4	Veeva Systems VEEV	Filing · EDGAR
Apr 1, 2021	Form 4	BiomX	Filing · EDGAR
Mar 26, 2021	Form 4	Veeva Systems VEEV	Filing · EDGAR
Mar 11, 2021	Form 3	Longboard Pharmaceuticals LBPH	Filing · EDGAR
Dec 28, 2020	Form 4	Veeva Systems VEEV	Filing · EDGAR
Oct 5, 2020	Form 4	BiomX	Filing · EDGAR
Oct 5, 2020	Form 3	BiomX	Filing · EDGAR
Sep 28, 2020	Form 4	Veeva Systems VEEV	Filing · EDGAR
Jun 26, 2020	Form 4	Veeva Systems VEEV	Filing · EDGAR
Jun 22, 2020	Form 4	Veeva Systems VEEV	Filing · EDGAR
Jun 5, 2020	Form 4	Veeva Systems VEEV	Filing · EDGAR
Mar 30, 2020	Form 4	Veeva Systems VEEV	Filing · EDGAR
Mar 23, 2020	Form 4	Veeva Systems VEEV	Filing · EDGAR
Jan 6, 2020	Form 4	Alpine Immune Sciences	Filing · EDGAR
Dec 20, 2019	Form 4	Veeva Systems VEEV	Filing · EDGAR
Dec 9, 2019	Form 4	Veeva Systems VEEV	Filing · EDGAR
Oct 8, 2019	Form 4	Veeva Systems VEEV	Filing · EDGAR
Sep 23, 2019	Form 4	Veeva Systems VEEV	Filing · EDGAR
Jun 25, 2019	Form 4	Veeva Systems VEEV	Filing · EDGAR
Jun 21, 2019	Form 4	Veeva Systems VEEV	Filing · EDGAR
Jun 17, 2019	Form 4	Veeva Systems VEEV	Filing · EDGAR
Mar 25, 2019	Form 4	Veeva Systems VEEV	Filing · EDGAR
Mar 15, 2019	Form 4	Veeva Systems VEEV	Filing · EDGAR
Jan 4, 2019	Form 4	Alpine Immune Sciences	Filing · EDGAR
Dec 27, 2018	Form 4	Veeva Systems VEEV	Filing · EDGAR
Dec 20, 2018	Form 4	Veeva Systems VEEV	Filing · EDGAR
Dec 14, 2018	Form 4	Veeva Systems VEEV	Filing · EDGAR
Dec 4, 2018	Form 4	Veeva Systems VEEV	Filing · EDGAR
Sep 26, 2018	Form 4	Veeva Systems VEEV	Filing · EDGAR
Sep 14, 2018	Form 4	Veeva Systems VEEV	Filing · EDGAR
Jun 27, 2018	Form 4	Veeva Systems VEEV	Filing · EDGAR
Jun 22, 2018	Form 4	Veeva Systems VEEV	Filing · EDGAR
Jun 15, 2018	Form 4	Veeva Systems VEEV	Filing · EDGAR
Mar 23, 2018	Form 4	Veeva Systems VEEV	Filing · EDGAR
Mar 1, 2018	Form 4	Veeva Systems VEEV	Filing · EDGAR
Jan 4, 2018	Form 4	Alpine Immune Sciences	Filing · EDGAR
Dec 22, 2017	Form 4	Veeva Systems VEEV	Filing · EDGAR
Dec 8, 2017	Form 4	Veeva Systems VEEV	Filing · EDGAR
Sep 25, 2017	Form 4	Veeva Systems VEEV	Filing · EDGAR
Jun 23, 2017	Form 4	Veeva Systems VEEV	Filing · EDGAR
Mar 24, 2017	Form 4	Veeva Systems VEEV	Filing · EDGAR
Dec 27, 2016	Form 4	Veeva Systems VEEV	Filing · EDGAR
Dec 13, 2016	Form 4	Enumeral Biomedical Holdings	Filing · EDGAR
Oct 13, 2016	Form 4	Veeva Systems VEEV	Filing · EDGAR
Sep 26, 2016	Form 4	Veeva Systems VEEV	Filing · EDGAR
Sep 14, 2016	Form 4	Alpine Immune Sciences	Filing · EDGAR
Jun 24, 2016	Form 4	Veeva Systems VEEV	Filing · EDGAR
Mar 2, 2016	Form 3	Alpine Immune Sciences	Filing · EDGAR
Sep 24, 2015	Form 4	Enumeral Biomedical Holdings	Filing · EDGAR
Jun 19, 2015	Form 4	Veeva Systems VEEV	Filing · EDGAR
Apr 3, 2015	Form 3	Enumeral Biomedical Holdings	Filing · EDGAR
Sep 4, 2014	Form 4	Veeva Systems VEEV	Filing · EDGAR
Jul 17, 2014	Form 3	Veeva Systems VEEV	Filing · EDGAR
May 3, 2010	Form 4	ARYx Therapeutics	Filing · EDGAR
May 1, 2009	Form 4	ARYx Therapeutics	Filing · EDGAR
Nov 9, 2007	Form 4	ARYx Therapeutics	Filing · EDGAR
Nov 7, 2007	Form 3	ARYx Therapeutics	Filing · EDGAR
May 10, 2007	Form 3	Biodel	Filing · EDGAR
Sep 13, 2004	Form 4	Ariad Pharmaceuticals	Filing · EDGAR
Oct 3, 2003	Form 4	Ariad Pharmaceuticals	Filing · EDGAR
Oct 3, 2003	Form 3	Ariad Pharmaceuticals	Filing · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.